Skip to content

MIMIX

Active Private limited companyfounded 2018active for 8 yearsAvenue de Vincennes 4, 6110 Montigny-le-TilleulKBO/BCE: BE 0698.573.808 #9 company by equity in Montigny-le-Tilleul, Health and social work sector

Lifetime

8 annual accounts with figures on one time axis
peak of €540,614 in 2024
€356,883▼ 34.0%
peak of €313,075 in 2023
€266,521▼ 14.0%
peak of €328,593 in 2024
€328,593unchanged
€66,159▼ 27.2%
Board1 name since 2018
1 director
Documentsfilings and deeds
13-07-202618 days before the deadline
2025micro format
Gross margin from €540,614 to €356,883Dividend €266,521Debts from €90,890 to €66,159Cash from €150,263 to €28,607

Key points

from the 2025 annual accounts

Equity

€328,593 =
328,5932024+266,521Profit-266,521Dividend328,5932025

MIMIX paid out €266,521 in dividends. That is 100% of the 2025 profit.

Filings

8 annual accounts 4 late
AprilJune31 JulyOctober20202025

The 2019 accounts came in latest, 52 days after the end of the period.

Position in the sector

€266,521

Higher net result than 93% of companies in human health. The sector median is €59,520, over 21,372 companies.

Checked score

Bankruptcy probability within 12 months

Financial strength

Score breakdown

Comparable companies, two years later

In July 2024, 26,972 companies had the same profile as MIMIX has now. Each dot stands for 68 companies, two years later.

94.9%
were still trading
3.5%
stopped another way
1.6%
went bankrupt
  • Micro
  • 5 to 10 years old
  • solvency 30% or more
  • a profit of 5% of the balance sheet or more
Test of the method

The method was tested on the 497,894 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.7% would go bankrupt within 24 months. In fact 1.8% went bankrupt.

The companies in ten equal groups, from the lowest to the highest expected share
Group Expected Actual
1 0.2% 0.2%
2 0.4% 0.5%
3 0.6% 0.6%
4 0.7% 0.8%
5 0.9% 1.0%
6 1.4% 1.6%
7 1.7% 1.8%
8 1.9% 2.0%
9 3.1% 3.3%
10 5.9% 6.4%

A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.

This is an observation about 26,972 companies, not a prediction for MIMIX. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.

Credit verdict

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Board and ownership

Director, since 01-01-2018
  • 186 sharesdeed of 21-06-2018
Board & ownership

Recent changes

Registered office moved within Montigny-le-Tilleul The registered office moved from rue Léon Dubray 20 à 6110 Montigny-le-Tilleul to Avenue de Vincennes 4 à 6110 Montigny-le-Tilleul · General meeting of 17-03-2026 · Gazette deed
Registered in the Peppol Directory Reachable for e-invoices through 0208:0698573808
Company renamed from DR MICHALAKIS N. to MIMIX changes role from manager to director · Legal-form conversion: from private limited company (pre-2019) to private limited company · General meeting of 17-11-2023 · Gazette deed
is in office as manager Capital €18,600, annual accounts 2018 · Gazette deed
All 18 events

Comparable companies

same main activity, similar in size and age
Company
MIMIX Montigny-le-Tilleul €394,752 €356,883 83.2% -
dr. Vandenbussche Pieter, orthopedie Celles (lez-Tournai) €404,210 €383,649 65.9% -
Docteur Oléna Golub Ixelles €385,190 €367,832 27.8% -
DOKTER VANHALST JOKE Izegem €411,367 €375,947 4.5% -
SCHELFAUT DAN Asse €421,614 €384,422 1.0% -
Dr. NJ HENDRICKX Kontich €374,029 €384,922 5.5% -
Dokter Virginie Cuypers Tielt €381,814 €359,329 69.2% -

These companies have the same main activity as MIMIX: specialist medical practice (NACE 86220). They are comparable in size and age: total assets between €374,000 and €422,000, founded between 2017 and 2019.

Official details

Source: KBO
Status
Active since 19-06-2018Normal situation
Activity
Specialist medical practiceNACE 86220
Establishment unit
2.277.417.9636110 Montigny-le-Tilleul, since 19-06-2018
Financial year end
31 December
Peppol
Reachable since 26-11-2025
Company details

Annual accounts 2025

≈ €540,000estimated
€394,752▼ 5.9%
Filing
Filed on 13-07-2026, 18 days before the end of the filing period
Financials

Insights on MIMIX

MIMIX files the micro format. That format states no turnover. The gross margin rose from €207,308 in 2018 to €356,883 in 2025.

Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.

Key facts about MIMIX

What is the company number of MIMIX?
The company number of MIMIX is 0698.573.808. The VAT number is the same number with BE in front: BE 0698.573.808.
Where is MIMIX based?
The registered office is at Avenue de Vincennes 4, 6110 Montigny-le-Tilleul.Company details
What does MIMIX do?
According to the KBO register, the main activity is specialist medical practice (NACE 86220).
What is the legal form of MIMIX?
MIMIX is a private limited company (BV).
When was MIMIX founded?
MIMIX was founded on 19-06-2018.
Is MIMIX still active?
Yes, MIMIX is an active enterprise in the KBO register.
What is the turnover of MIMIX?
The turnover in financial year 2025 is about €540,000. This figure is estimated from the gross margin of €356,883 and 31 comparable companies (NACE 86220). It probably lies between €480,000 and €750,000.Financials
Is MIMIX profitable?
In financial year 2025, MIMIX made a profit of €266,521.
Where can I find the annual accounts of MIMIX?
MIMIX filed 8 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of MIMIX due?
MIMIX must file the annual accounts for financial year 2026 by 31-07-2027.Timeline

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.